CAPS Rating

mitchdowd (< 20)

Results 1 - 20 of 61 : 1 2 3 4 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
21/03/2013 CHTP.US 1 out of 5 Underperform 5Y $1.87 $1.84 (-3.16%) -1.34% +6.87% +8.21
24/05/2012 ATLO.US 1 out of 5 Underperform 5Y $19.74 $20.36 (+0.89%) +3.14% +24.81% +21.66
22/05/2012 GENE.US 1 out of 5 Underperform 5Y $3.85 $3.10 (-0.32%) -19.48% +25.42% +44.90
22/05/2012 PACB.US 3 out of 5 Outperform 5Y $2.22 $2.60 (+0.39%) +17.12% +24.83% -7.71
22/05/2012 HNSN.US 4 out of 5 Outperform 5Y $2.32 $1.63 (-1.81%) -29.74% +24.65% -54.39
21/05/2012 VRML.US 1 out of 5 Underperform 5Y $1.80 $3.08 (+0.39%) +71.11% +25.82% -45.29
18/05/2012 AINV.US 5 out of 5 Underperform 5Y $6.05 $8.58 (-0.98%) +41.86% +26.42% -15.43
16/05/2012 CGR.US 3 out of 5 Outperform 5Y $0.58 $0.26 (-0.58%) -55.43% +23.55% -78.98
14/05/2012 JAG.US 2 out of 5 Outperform 5Y $1.43 $0.38 (-0.80%) -73.32% +23.11% -96.42
19/04/2012 GFIG.US 2 out of 5 Outperform 5Y $2.98 $4.24 (+1.68%) +42.32% +20.23% +22.09
19/04/2012 CEL.US 4 out of 5 Outperform 5Y $11.30 $8.72 (-0.11%) -22.81% +19.02% -41.83
19/04/2012 PRMW.US 4 out of 5 Outperform 5Y $1.60 $1.58 (+1.28%) -1.25% +19.09% -20.34
19/04/2012 LIME.US 3 out of 5 Outperform 5Y $2.91 $0.75 (+4.02%) -74.23% +19.58% -93.81
18/04/2012 AAV.US 4 out of 5 Outperform 5Y $2.99 $4.41 (+1.15%) +47.49% +18.96% +28.53
29/05/2012 CYTK.US 3 out of 5 Outperform 5Y $0.91 $1.16 (-1.69%) +27.61% +24.36% +3.26
31/05/2012 ONXX.US 2 out of 5 Underperform 5Y $45.64 $95.23 (-1.01%) +108.65% +25.34% -83.31
19/03/2013 MACK.US 5 out of 5 Outperform 5Y $6.07 $5.20 (-1.14%) -14.33% +6.41% -20.74
18/03/2013 AAPL.US 4 out of 5 Outperform 5Y $446.01 $445.15 (+0.68%) -0.19% +6.51% -6.71
12/12/2012 ACUR.US 2 out of 5 Underperform 5Y $3.12 $2.37 (+0.42%) -24.04% +14.72% +38.76
25/09/2012 URRE.US 2 out of 5 Outperform 5Y $5.29 $2.67 (+4.30%) -49.57% +13.10% -62.67
Results 1 - 20 of 61 : : 1 2 3 4 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.